Nuo Therapeutics, Inc. (AURX) Operating cash flow 2015–2025
Nuo Therapeutics, Inc. (AURX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$864,971FY2025 · since FY2015: -$14.4M → -$864,971
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$864,971 | +61.2% |
| FY2024 | -$2.2M | +29.6% |
| FY2023 | -$3.2M | +14.5% |
| FY2022 | -$3.7M | -2989.6% |
| FY2021 | -$119,955 | -122.9% |
| FY2020 | -$53,821 | +94.2% |
| FY2019 | -$921,674 | -5.4% |
| FY2018 | -$874,388 | +82.2% |
| FY2017 | -$4.9M | — |
| FY2015 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice